Observational Active not recruiting
NCT04975594 on ClinicalTrials.gov
Statin-Intolerance Registry
- Sponsor: Leipzig University
- Collaborators: University of Jena, University Hospital Dresden, Charite University, Berlin, Germany
- Enrollment: 1000 (Estimated)
- Study start: 2021-08-01 (Actual)
- Primary completion: 2026-08-01 (Estimated)
- Study completion: 2026-08-01 (Estimated)
- Allocation: N/a
- InterventionModel: N/a
- Masking: None
- PrimaryPurpose: Other
Brief Summary
The Statin-Intolerance Registry will characterize the patient population suffering from statin-intolerance which is a frequent but incompletely understood patient condition with important clinical implications for atherosclerotic cardiovascular disease (ASCVD) prevention.
Patients will be systematically and prospectively included and followed by the registry.
Conditions
- Dyslipidemias
Primary Outcome Measures
- Number of treatment adjustments (3 years)
- Change in LDL cholesterol level (3 years)
Countries
Germany
Locations and Investigators
- Uniklinik Leipzig, Leipzig, Germany
Study Officials
- Ulrich Laufs (Study Director) — University of Leipzig